Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Scalp Cooling in MBC [Phase 2]
Phase 2 clinical trial from Dana-Farber Cancer Institute evaluating scalp cooling to prevent chemotherapy-induced alopecia in patients with …
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Evaluation of the Cardioprotective Effect of Nebivolol on Trastuzumab-Induced Cardiotoxicity in Breast Cancer Patients [Phase 2]
A Phase 2 clinical trial is evaluating whether nebivolol can protect against trastuzumab-induced cardiotoxicity in patients with HER2-positi…
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Living Well Program: Impact on Healthcare Costs and Clinical Outcomes in Breast Cancer Care [NA]
Clinical trial update for a Living Well Program assessing its impact on healthcare costs and clinical outcomes in breast cancer care. The st…
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Adjuvant Therapy With Abemaciclib + SOC ET vs. SOC ET in Clinical or Genomic High Risk, HR+/HER2- EBC [Phase 3]
A Phase 3 trial is evaluating adjuvant abemaciclib in combination with standard endocrine therapy versus standard therapy alone in high-risk…
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Adjuvant CDK4/6 Inhibitor Use in HR+/HER2- Breast Cancer
A clinical trial update announcing recruitment for a study evaluating adjuvant CDK4/6 inhibitors in hormone receptor-positive, HER2-negative…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Iparomlimab and Tuvonralimab (QL1706) in Patients With HR-positive, HER2-negative Advanced Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating iparomlimab and tuvonralimab (QL1706) in HR-positive, HER2-negative advanced breast cancer is currently re…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Continuous or Intermittent Extension of Adjuvant Pyrotinib for Invasive HER2-positive Breast Cancer [Phase 3]
A Phase 3 trial is evaluating continuous or intermittent extension of adjuvant pyrotinib for invasive HER2-positive breast cancer.
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer [NA]
This clinical trial tests a targeted palliative care intervention for patients with metastatic breast cancer and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Capecitabine, Tucatinib, and Intrathecal Trastuzumab for Breast Cancer Patients With Leptomeningeal Disease [Phase 2]
Phase 2 clinical trial evaluating capecitabine, tucatinib, and intrathecal trastuzumab for leptomeningeal metastasis/disease in HER2-positiv…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Hypofractionated LocoRegional Radiotherapy in Breast Cancer [Phase 3]
Phase 3 trial status update indicates hypofractionated loco-regional radiotherapy for breast cancer is active but not recruiting.
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Trastuzumab Deruxtecan in Advanced Breast Cancer
A clinical trial update indicates that a study evaluating trastuzumab deruxtecan for advanced breast cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: DS8201a and Pembrolizumab in Participants With Locally Advanced/Metastatic Breast or Non-Small Cell Lung Cancer [Phase 1]
Phase 1 trial of DS8201a (trastuzumab deruxtecan) in combination with pembrolizumab for locally advanced/metastatic breast cancer or non-sma…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Study of Sexual Quality of Life in Women With Breast Cancer Who Had Multidisciplinary Management With Photobiomodulation for Genitourinary Syndrome of the Menopause [NA]
A study evaluating sexual quality of life in women with breast cancer who received multidisciplinary management including photobiomodulation…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Preventing Chemotherapy-induced Peripheral Neuropathy Using PRESIONA Exercise Program [NA]
A clinical trial sponsored by Universidad de Granada is evaluating the PRESIONA exercise program to prevent chemotherapy-induced peripheral …
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Radiation OmisSion in PAtients With CLinically Node Negative Breast Cancer Undergoing Lumpectomy
Clinical trial update describing a study that investigates omitting radiation therapy for patients with clinically node-negative breast canc…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Continuous or Intermittent Pyrotinib for HER2-positive Advanced Breast Cancer [Phase 2]
A Phase 2 study is evaluating continuous or intermittent dosing of pyrotinib in HER2-positive advanced breast cancer, and the trial is curre…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Evaluation of Sleep Quality in Prostate Cancer Patients Undergoing Treatment With Hormonal Therapeutic Approaches and in Patients With Full-resected Early Breast Cancer
This ClinicalTrials.gov update describes a study evaluating sleep quality in prostate cancer patients receiving hormonal therapy and in pati…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Low Dose Exemestane vs Low Dose Tamoxifen in Post-menopausal Women at High Risk for Breast Cancer. [Phase 2]
A Phase 2 clinical trial is comparing low-dose exemestane with low-dose tamoxifen in post-menopausal women at high risk for breast cancer an…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Korea Post Marketing Surveillance (PMS) Study of Talzenna®
This is a Korea post-marketing surveillance study for Talzenna (talazoparib) focusing on breast cancer; the trial is currently not yet recru…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Are CK+/CD45+ Double-Positive Circulating Cells of Tumor-origin? Characterization in METAstatic Breast Cancer [NA]
A completed clinical trial evaluating whether CK+/CD45+ double-positive circulating cells are of tumor origin in metastatic breast cancer.
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Arm Swelling Occurence in Breast Cancer Patients With Nodal Radiotherapy: Impact of Informing Them of AI-predicted Risk [NA]
A clinical trial update investigates arm swelling (lymphedema) in breast cancer patients receiving nodal radiotherapy and whether informing …
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: A Study of MHB036C Combined With MHB039A in Patients With Advanced Breast Cancer or Other Advanced Malignant Solid Tumors [Phase 2]
This clinical trial update describes a Phase 2 study evaluating MHB036C in combination with MHB039A in patients with advanced breast cancer …
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Geriatric Oncology Assessment and Coping Skills Training for Older Women on Aromatase Inhibitor Therapy [NA]
This ClinicalTrials.gov entry describes a planned study evaluating geriatric assessment and coping skills training for older women with horm…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: RC48-ADC in HER2-low Advanced Breast Cancer [NA]
A clinical trial update indicates that RC48-ADC is being studied in HER2-low advanced breast cancer and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: IvoLoC Trial: A Phase II Trial Evaluating the Efficacy of Ivonescimab in Metastatic Endocrine Refractory HR-positive HER2-negative or Triple Negative Invasive Lobular Carcinoma [Phase 2]
A Phase II clinical trial evaluating Ivonescimab in metastatic endocrine-refractory HR-positive/HER2-negative breast cancer and metastatic t…